Building systems company Limbach (NASDAQ: LMB) missed Wall Street’s revenue expectations in Q2 CY2026, but sales rose 21.9% year on year to $173.5 million. On the other hand, the company’s full-year revenue guidance of $775 million at the midpoint came in 4.3% above analysts’ estimates. Its non-GAAP profit of $0.64 per share was 30.9% below analysts’ consensus estimates.

Is now the time to buy Limbach? Find out by accessing our full research report, it’s free.

Company Overview

Established in 1901, Limbach (NASDAQ: LMB) provides integrated building systems solutions, including mechanical, electrical, and plumbing services.

Revenue Growth

A company’s long-term performance is an indicator of its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Regrettably, Limbach’s sales grew at a tepid 5.3% compounded annual growth rate over the last five years. This wasn’t a great result compared to the rest of the industrials sector, but there are still things to like about Limbach.

We at StockStory place the most emphasis on long-term growth, but within industrials, a half-decade historical view may miss cycles, industry trends, or a company capitalizing on catalysts such as a new contract win or a successful product line. Limbach’s annualized revenue growth of 15.6% over the last two years is above its five-year trend, suggesting its demand recently accelerated.

This quarter, Limbach generated an excellent 21.9% year-on-year revenue growth rate, but its $173.5 million of revenue fell short of Wall Street’s high expectations.

Looking ahead, sell-side analysts expect revenue to grow 10.5% over the next 12 months, a deceleration versus the last two years. Despite the slowdown, this projection is commendable and indicates the market sees success for its products and services.

WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.

This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.

Operating Margin

Operating margin is a key measure of profitability. Think of it as net income - the bottom line - excluding the impact of taxes and interest on debt, which are less connected to business fundamentals.

Limbach was profitable over the last five years but held back by its large cost base. Its average operating margin of 5.9% was weak for an industrials business. This result isn’t too surprising given its low gross margin as a starting point.

On the plus side, Limbach’s operating margin rose by 2.9 percentage points over the last five years, as its sales growth gave it operating leverage.

In Q2, Limbach generated an operating margin profit margin of 4.2%, down 3.9 percentage points year on year. Since Limbach’s gross margin decreased more than its operating margin, we can assume its recent inefficiencies were driven more by weaker leverage on its cost of sales rather than increased marketing, R&D, and administrative overhead expenses.

Earnings Per Share

We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.

Limbach’s EPS grew at 50.2% compounded annual growth rate over the last five years, higher than its 5.3% annualized revenue growth. This tells us the company became more profitable on a per-share basis as it expanded.

Diving into the nuances of Limbach’s earnings can give us a better understanding of its performance. As we mentioned earlier, Limbach’s operating margin declined this quarter but expanded by 2.9 percentage points over the last five years. This was the most relevant factor (aside from the revenue impact) behind its higher earnings; interest expenses and taxes can also affect EPS but don’t tell us as much about a company’s fundamentals.

Like with revenue, we analyze EPS over a shorter period to see if we are missing a change in the business.

For Limbach, its two-year annual EPS growth of 20% was lower than its five-year trend. We still think its growth was good and hope it can accelerate in the future.

In Q2, Limbach reported adjusted EPS of $0.64, down from $0.93 in the same quarter last year. This print missed analysts’ estimates, but we care more about long-term adjusted EPS growth than short-term movements. Over the next 12 months, Wall Street expects Limbach’s full-year EPS to grow 21.7% from $3.73 to $4.54.

Key Takeaways from Limbach’s Q2 Results

We were impressed by Limbach’s optimistic full-year revenue guidance, which blew past analysts’ expectations. On the other hand, its full-year EBITDA guidance missed and its revenue fell short of Wall Street’s estimates. Overall, this quarter could have been better. The stock traded down 10.1% to $69.16 immediately following the results.

The latest quarter from Limbach’s wasn’t that good. One earnings report doesn’t define a company’s quality, though, so let’s explore whether the stock is a buy at the current price. The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here (it’s free).